Nursing aides plagued by PTSD after ‘nightmare’ covid conditions, with little help

One evening in May, nursing assistant Debra Ragoonanan’s vision blurred during her shift at a state-run Massachusetts veterans home.

Outpatient CAR-T therapy shows promise for treating lymphoma patients

In the largest prospective study to date examining the use of chimeric antigen receptor (CAR)-T therapy in a community setting on an outpatient basis, patients

September 30, 2024

ASCO 24: Sanofi’s Sarclisa looks to gain an edge in multiple myeloma – Pharmaceutical Technology

Sarclisa is a CD38-directed cytolytic human monoclonal antibody that received its first FDA approval for the treatment of adults with previously multiple myeloma. Credits: nitpicker

June 4, 2024

Study finds higher heart attack risk days after cold exposure

Hospital admissions for heart attacks increase after exposure to lower air temperature and cold spells, according to a study published today in JACC, the flagship

September 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.